Lower serum calcium level is associated with hemorrhagic transformation after thrombolysis

Stroke. 2015 May;46(5):1359-1361. doi: 10.1161/STROKEAHA.115.008992. Epub 2015 Mar 26.

Abstract

Background and purpose: We aim to investigate whether lower admission serum calcium levels are associated with hemorrhagic transformation (HT) after intravenous thrombolysis (IVT).

Methods: A total of 362 patients treated with IVT was divided into 4 quartiles based on admission serum calcium levels (Q1[<2.16], Q2[2.16, 2.23], Q3[2.24, 2.31], and Q4[>2.31] mmol/L). HT was classified as hemorrhagic infarction and parenchymal hemorrhage. Logistic regression was applied to assess the association between serum calcium levels and the incidence of HT.

Results: Compared with Q4, HT was more common in Q1 (odds ratio, 2.580; 95% CI, [1.258-5.292]; P=0.010), Q2 (odds ratio, 2.382; 95% CI, [1.163-4.877]; P=0.018), and Q3 (odds ratio, 2.293; 95% CI, [1.133-4.637]; P=0.021). Hemorrhagic infarction was more common in Q1 (P=0.037), and Q2 (P=0.018), compared with Q4, and parenchymal hemorrhage was more common in Q1 (P=0.029) than Q4.

Conclusions: Lower admission serum calcium level is independently associated with HT after IVT, and this hypothesis needs larger confirmatory trials.

Keywords: serum-calcium-decreasing factor; stroke; thrombolytic therapy.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Calcium / blood*
  • Disease Progression
  • Humans
  • Intracranial Hemorrhages / etiology*
  • Middle Aged
  • Prospective Studies
  • Stroke / complications*
  • Stroke / therapy
  • Thrombolytic Therapy / adverse effects*
  • Young Adult

Substances

  • Calcium